Table: begin end state 1 11 non-cytoplasmic 12 37 transmembrane 38 40 cytoplasmic 41 71 transmembrane 72 105 non-cytoplasmic 106 133 transmembrane 134 142 cytoplasmic 143 161 transmembrane 162 166 non-cytoplasmic 167 186 transmembrane 187 197 cytoplasmic 198 221 transmembrane 222 255 non-cytoplasmic 256 279 transmembrane 280 313 cytoplasmic 314 337 transmembrane 338 354 non-cytoplasmic 355 377 transmembrane 378 388 cytoplasmic 389 405 transmembrane 406 410 non-cytoplasmic 411 426 transmembrane 427 429 non-cytoplasmic 430 432 cytoplasmic 433 451 transmembrane 452 467 non-cytoplasmic 468 488 transmembrane 489 498 cytoplasmic
Input: >HSERO_RS16690 MFANIYAAFGMVFDPYVLAVILGSSIFGLFMGAVPGLSATMAVALLVPVTFFMPPVPAIA AMVSATAMAIFSGDIPGCLLRIPGTPSSAAYTDEAYAMTMKGQGEIALGASLVFSVIGGL FGTFVLILAAPALAELALKFSSFEYFWLVLLGLTCAIFIASDNPLKGFVSLFLGMFIASI GMGNPAGAPRFTFDQPDLLGGVSLVPLMVGMFAMSEVLRFAVSRDFSMKVAESRVGNVFK GMWGLMIKYPKSVLRGSVLGTLVGALPGAGADIAAWMSYAMSKKLSKEPEKFGTGHPEGI VESGAANNSALAGAWIPALVFGIPGDSITAIVIGVLYMKNLNPGPMIFVENPVSMYAIFI VFILANLLMLPLGFWCIKMAKRILSIPRGILMPLILLFCIVGSYATNNSVTDVGIMLVFG LLAYVMEENGFPVAPAVLGVVLGGMLEEHFVTSMIKADGQFLAFFERPIAGTLGVITLLL WLLPLALKLVRRKTLATA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server